1753P Cost-effectiveness (CE) of nivolumab (NIVO) as adjuvant treatment of muscle invasive urothelial carcinoma at high risk of recurrence (MIUC-HR) in France von Negrier, M.S., Colrat, F.P., Bonastre, J., Chamielec, C., Teitsson, S., Knight, C., Ni, L., Chevalier, J., Gaudin, A-F., Roupret, M., Branchoux, S.

Volltext

7130 Efficacy and safety of sorafenib in patients with advanced clear-cell renal-cell carcinoma (RCC) with bone metastases: results from the phase III target study von Bukowski, R, Eisen, T.E, Stadler, W.S, Szczylik, C.S, Oudard, O.S, Siebels, M.S, Negrier, S.N, Anderson, S.A, Shan, M.S, Escudier, B.E

Volltext

Time-to-event analysis with artificial neural networks: An integrated analytical and rule-based study for breast cancer von Lisboa, Paulo J.G., Etchells, Terence A., Jarman, Ian H., Hane Aung, M.S., Chabaud, Sylvie, Bachelot, Thomas, Perol, David, Gargi, Thérèse, Bourdès, Valérie, Bonnevay, Stéphane, Négrier, Sylvie

Volltext

Breast Cancer Predictions by Neural Networks Analysis: a Comparison with Logistic Regression von Bourdes, V.S., Bonnevay, S., Lisboa, P.J.G., Aung, M.S.H., Chabaud, S., Bachelot, T., Perol, D., Negrier, S.

Volltext

Development of a Rule Based Prognostic Tool for HER 2 Positive Breast Cancer Patients von Lisboa, Paulo J.G., Bonnevay, Stephane, Negrier, Sylvie, Etchells, Terence A., Jarman, Ian H., Aung, M.S. Hane, Chabaud, Sylvie, Bachelot, Thomas, Perol, David, Gargi, Therese, Bourdes, Valerie

Volltext

Time-to-event analysis with artificial neural networks: An integrated analytical and rule-based study for breast cancer von Lisboa, Paulo J.G., Bonnevay, Stephane, Negrier, Sylvie, Etchells, Terence A., Jarman, Ian H., Aung, M.S. Hane, Chabaud, Sylvie, Bachelot, Thomas, Perol, David, Gargi, Therese, Bourdes, Valerie

Volltext